Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer.

Nature genetics·2026

Organ-specific colonization and niche remodeling in a human tissue model of metastasis.

Science translational medicine·2026

Fifteen challenges for generative AI applications to cell biology.

Cell·2026

CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.

Neuro-oncology·2026

A compendium of next-generation patient-derived models for diverse cancers.

Nature·2026

Complex assembly and activity states as multifaceted protein attributes explaining phenotypic variability.

Molecular systems biology·2026

International breast density and cancer risk assessment workshop: advances, challenges, and emerging solutions, a summary from the 11th IBDW, Kaua'i 2025.

Breast cancer research : BCR·2026

Computational methods, clinical evidence, and translational readiness for artificial intelligence for HER2 assessment using silver in situ hybridization (SISH).

Breast cancer research : BCR·2026

Synergistic lethality of combination treatment with Trop2-directed antibody-drug conjugate sacituzumab govitecan and TRAIL agonists in triple negative breast cancer.

Breast cancer research : BCR·2026

Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.

Breast cancer research : BCR·2026

Enhancing lymph node metastases assessment in breast cancer post-neoadjuvant therapy using artificial intelligence-driven diagnostics.

Breast cancer research : BCR·2026

The association between adiposity and cardiac function in patients with early breast cancer receiving cardiotoxic therapies.

Breast cancer research : BCR·2026

Corrigendum to: ARL6IP1 Inhibits Breast Cancer Tumor Progression by Targeting OLFM4 to Regulate Glycolysis.

Combinatorial chemistry & high throughput screening·2026

Claudin 18 is not a biomarker for breast mucinous tumor.

Journal of the Chinese Medical Association : JCMA·2026

Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.

Journal of the National Cancer Institute·2026

Neurodevelopmental Disorder Associated with Aluminum-Adsorbed Vaccines: Reanalysis of Data from a Danish Nationwide Cohort Study.

Integrative medicine (Encinitas, Calif.)·2026

Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study.

EClinicalMedicine·2026

Systematic review of PET imaging features and clinical applications in pulmonary NUT carcinoma.

Frontiers in radiology·2026

Related Experiment Videos

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

Related Concept Videos

Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer.

Organ-specific colonization and niche remodeling in a human tissue model of metastasis.

Fifteen challenges for generative AI applications to cell biology.

CD155 regulates tumor growth and susceptibility to T cell mediated killing in diffuse midline glioma.

A compendium of next-generation patient-derived models for diverse cancers.

Complex assembly and activity states as multifaceted protein attributes explaining phenotypic variability.

International breast density and cancer risk assessment workshop: advances, challenges, and emerging solutions, a summary from the 11th IBDW, Kaua'i 2025.

Computational methods, clinical evidence, and translational readiness for artificial intelligence for HER2 assessment using silver in situ hybridization (SISH).

Synergistic lethality of combination treatment with Trop2-directed antibody-drug conjugate sacituzumab govitecan and TRAIL agonists in triple negative breast cancer.

Variation in chemotherapy use across healthcare regions in Sweden and its impact on prognosis in women with HR+/HER2- early breast cancer.

Enhancing lymph node metastases assessment in breast cancer post-neoadjuvant therapy using artificial intelligence-driven diagnostics.

The association between adiposity and cardiac function in patients with early breast cancer receiving cardiotoxic therapies.

Corrigendum to: ARL6IP1 Inhibits Breast Cancer Tumor Progression by Targeting OLFM4 to Regulate Glycolysis.

Claudin 18 is not a biomarker for breast mucinous tumor.

Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.

Neurodevelopmental Disorder Associated with Aluminum-Adsorbed Vaccines: Reanalysis of Data from a Danish Nationwide Cohort Study.

Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study.

Systematic review of PET imaging features and clinical applications in pulmonary NUT carcinoma.

Related Experiment Videos

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers

Related Concept Videos

Related Articles